Search

Eric Olson

Examiner (ID: 316, Phone: (571)272-9051 , Office: P/1673 )

Most Active Art Unit
1623
Art Unit(s)
1693, 1673, 1623
Total Applications
1758
Issued Applications
971
Pending Applications
175
Abandoned Applications
632

Applications

Application numberTitle of the applicationFiling DateStatus
13/215394 FERMENTATIVE PRODUCTION OF SOPHOROLIPIDS FROM SOYBEAN AND OTHER VEGETABLE OILS Aug 22, 2011 Abandoned
Array ( [id] => 8944181 [patent_doc_number] => 08497361 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-07-30 [patent_title] => 'Topoisomerase binding probe and method of use' [patent_app_type] => utility [patent_app_number] => 13/215175 [patent_app_country] => US [patent_app_date] => 2011-08-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 12 [patent_no_of_words] => 7831 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 113 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13215175 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/215175
Topoisomerase binding probe and method of use Aug 21, 2011 Issued
Array ( [id] => 8199527 [patent_doc_number] => 20120122935 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-05-17 [patent_title] => 'COMPOSITIONS AND METHODS FOR TREATING NECROTIZING ENTEROCOLITIS' [patent_app_type] => utility [patent_app_number] => 13/211229 [patent_app_country] => US [patent_app_date] => 2011-08-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 9539 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0122/20120122935.pdf [firstpage_image] =>[orig_patent_app_number] => 13211229 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/211229
COMPOSITIONS AND METHODS FOR TREATING NECROTIZING ENTEROCOLITIS Aug 15, 2011 Abandoned
Array ( [id] => 9648820 [patent_doc_number] => 08802832 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-08-12 [patent_title] => 'Compositions comprising noribogaine and an excipient to facilitate transport across the blood brain barrier' [patent_app_type] => utility [patent_app_number] => 13/198593 [patent_app_country] => US [patent_app_date] => 2011-08-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12641 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13198593 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/198593
Compositions comprising noribogaine and an excipient to facilitate transport across the blood brain barrier Aug 3, 2011 Issued
Array ( [id] => 8822161 [patent_doc_number] => 20130123206 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-05-16 [patent_title] => 'TREATMENT OF METABOLIC SYNDROME AND INSULIN RESISTANCE WITH CITRUS FLAVANONES' [patent_app_type] => utility [patent_app_number] => 13/813072 [patent_app_country] => US [patent_app_date] => 2011-07-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 17981 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13813072 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/813072
TREATMENT OF METABOLIC SYNDROME AND INSULIN RESISTANCE WITH CITRUS FLAVANONES Jul 28, 2011 Abandoned
Array ( [id] => 8976120 [patent_doc_number] => 20130209550 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-08-15 [patent_title] => 'Anti-Viral Azide Containing Compounds' [patent_app_type] => utility [patent_app_number] => 13/812807 [patent_app_country] => US [patent_app_date] => 2011-07-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 16913 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13812807 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/812807
Anti-Viral Azide Containing Compounds Jul 27, 2011 Abandoned
Array ( [id] => 9518843 [patent_doc_number] => 20140155336 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-06-05 [patent_title] => 'WATER-SOLUBLE CAMPTOTHECIN DERIVATIVE, PHARMACEUTICAL COMPOSITION AND USE THEREOF' [patent_app_type] => utility [patent_app_number] => 14/235158 [patent_app_country] => US [patent_app_date] => 2011-07-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 7913 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14235158 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/235158
Water-soluble camptothecin derivative, pharmaceutical composition and use thereof Jul 26, 2011 Issued
Array ( [id] => 8617350 [patent_doc_number] => 20130022663 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-01-24 [patent_title] => 'Method of making and using a topical medicated formula and delivery system to use to prevent and treat breast diseases and breast cancer as well as use as skin wellness and anti-wrinkle formula' [patent_app_type] => utility [patent_app_number] => 13/135920 [patent_app_country] => US [patent_app_date] => 2011-07-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3604 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13135920 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/135920
Method of making and using a topical medicated formula and delivery system to use to prevent and treat breast diseases and breast cancer as well as use as skin wellness and anti-wrinkle formula Jul 18, 2011 Abandoned
Array ( [id] => 7663787 [patent_doc_number] => 20110313056 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-12-22 [patent_title] => 'GEL FORMATION OF POLYELECTROLYTE AQUEOUS SOLUTIONS BY THERMALLY INDUCED CHANGES IN IONIZATION STATE' [patent_app_type] => utility [patent_app_number] => 13/184953 [patent_app_country] => US [patent_app_date] => 2011-07-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 13832 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0313/20110313056.pdf [firstpage_image] =>[orig_patent_app_number] => 13184953 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/184953
GEL FORMATION OF POLYELECTROLYTE AQUEOUS SOLUTIONS BY THERMALLY INDUCED CHANGES IN IONIZATION STATE Jul 17, 2011 Abandoned
Array ( [id] => 8301051 [patent_doc_number] => 20120183607 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-07-19 [patent_title] => 'STABLE DOSAGE FORMS OF SPIRO AND DISPIRO 1,2,4-TRIOXOLANE ANTIMALARIALS' [patent_app_type] => utility [patent_app_number] => 13/183119 [patent_app_country] => US [patent_app_date] => 2011-07-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7502 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13183119 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/183119
Stable dosage forms of spiro and dispiro 1,2,4-trioxolane antimalarials Jul 13, 2011 Issued
Array ( [id] => 7744320 [patent_doc_number] => 20120022012 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-01-26 [patent_title] => 'Glycosylated Acetaminophen Pro-Drug Analogs' [patent_app_type] => utility [patent_app_number] => 13/183222 [patent_app_country] => US [patent_app_date] => 2011-07-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 22001 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0022/20120022012.pdf [firstpage_image] =>[orig_patent_app_number] => 13183222 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/183222
Glycosylated acetaminophen pro-drug analogs Jul 13, 2011 Issued
Array ( [id] => 9047047 [patent_doc_number] => 08541600 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-09-24 [patent_title] => '11-aza, 11-thia and 11-oxa sterol compounds and compositions' [patent_app_type] => utility [patent_app_number] => 13/183275 [patent_app_country] => US [patent_app_date] => 2011-07-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 168120 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13183275 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/183275
11-aza, 11-thia and 11-oxa sterol compounds and compositions Jul 13, 2011 Issued
Array ( [id] => 10161297 [patent_doc_number] => 09192507 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-11-24 [patent_title] => 'Tissue crosslinking for treatment of snoring and obstructive sleep apnea' [patent_app_type] => utility [patent_app_number] => 13/704220 [patent_app_country] => US [patent_app_date] => 2011-06-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 2 [patent_no_of_words] => 6683 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 100 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13704220 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/704220
Tissue crosslinking for treatment of snoring and obstructive sleep apnea Jun 27, 2011 Issued
Array ( [id] => 9273716 [patent_doc_number] => 08637648 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2014-01-28 [patent_title] => 'Compositions comprising noribogaine and an excipient to facilitate transport across the blood brain barrier' [patent_app_type] => utility [patent_app_number] => 13/165642 [patent_app_country] => US [patent_app_date] => 2011-06-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11731 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13165642 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/165642
Compositions comprising noribogaine and an excipient to facilitate transport across the blood brain barrier Jun 20, 2011 Issued
Array ( [id] => 7515529 [patent_doc_number] => 08039601 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2011-10-18 [patent_title] => 'Crystalline forms of 1,6-Bis [3-(3-carboxymethylphenyl)-4-(2-α-D-mannopyranosyloxy)-phenyl] hexane' [patent_app_type] => utility [patent_app_number] => 13/159875 [patent_app_country] => US [patent_app_date] => 2011-06-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 16058 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/039/08039601.pdf [firstpage_image] =>[orig_patent_app_number] => 13159875 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/159875
Crystalline forms of 1,6-Bis [3-(3-carboxymethylphenyl)-4-(2-α-D-mannopyranosyloxy)-phenyl] hexane Jun 13, 2011 Issued
Array ( [id] => 7696158 [patent_doc_number] => 20110230432 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-09-22 [patent_title] => 'COMPOSITIONS AND KITS FOR TREATING INFLUENZA' [patent_app_type] => utility [patent_app_number] => 13/116484 [patent_app_country] => US [patent_app_date] => 2011-05-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 17487 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0230/20110230432.pdf [firstpage_image] =>[orig_patent_app_number] => 13116484 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/116484
COMPOSITIONS AND KITS FOR TREATING INFLUENZA May 25, 2011 Abandoned
Array ( [id] => 8043505 [patent_doc_number] => 20120071498 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-03-22 [patent_title] => 'THERAPEUTIC COMPOSITION TO TREAT LESIONS CAUSED BY HERPES SIMPLEX VIRUS' [patent_app_type] => utility [patent_app_number] => 13/116112 [patent_app_country] => US [patent_app_date] => 2011-05-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3467 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0071/20120071498.pdf [firstpage_image] =>[orig_patent_app_number] => 13116112 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/116112
Therapeutic composition to treat lesions caused by herpes simplex virus May 25, 2011 Issued
Array ( [id] => 7580239 [patent_doc_number] => 20110294122 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-12-01 [patent_title] => 'Synthesis of 2\', 3\'-Dideoxynucleosides for Automated DNA Synthesis and Pyrophosphorolysis Activated Polymerization' [patent_app_type] => utility [patent_app_number] => 13/117029 [patent_app_country] => US [patent_app_date] => 2011-05-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11467 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0294/20110294122.pdf [firstpage_image] =>[orig_patent_app_number] => 13117029 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/117029
Synthesis of 2′,3′-dideoxynucleosides for automated DNA synthesis and pyrophosphorolysis activated polymerization May 25, 2011 Issued
Array ( [id] => 8490108 [patent_doc_number] => 20120289515 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-11-15 [patent_title] => 'Combination therapy for cognitive distortions, resisting relapse of unipolar non-psychotic depression' [patent_app_type] => utility [patent_app_number] => 13/068946 [patent_app_country] => US [patent_app_date] => 2011-05-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8410 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13068946 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/068946
Combination therapy for cognitive distortions, resisting relapse of unipolar non-psychotic depression May 24, 2011 Abandoned
Array ( [id] => 9518852 [patent_doc_number] => 20140155344 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-06-05 [patent_title] => 'COMBINATION THERAPY METHODS FOR TREATING PROLIFERATIVE DISEASES' [patent_app_type] => utility [patent_app_number] => 13/701001 [patent_app_country] => US [patent_app_date] => 2011-05-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 54748 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13701001 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/701001
COMBINATION THERAPY METHODS FOR TREATING PROLIFERATIVE DISEASES May 19, 2011 Abandoned
Menu